|
KIAA0182 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.861810E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.702000E-01 |
| Normal-vs-Stage2 |
4.531600E-01 |
| Normal-vs-Stage3 |
1.879750E-02 |
| Normal-vs-Stage4 |
3.059000E-03 |
| Stage1-vs-Stage2 |
1.602600E-01 |
| Stage1-vs-Stage3 |
3.989800E-02 |
| Stage1-vs-Stage4 |
4.458300E-03 |
| Stage2-vs-Stage3 |
9.204900E-03 |
| Stage2-vs-Stage4 |
4.060200E-03 |
| Stage3-vs-Stage4 |
4.989400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.093600E-01 |
| Normal-vs-AfricanAmerican |
9.232800E-01 |
| Normal-vs-Asian |
2.379400E-01 |
| Caucasian-vs-AfricanAmerican |
4.531000E-01 |
| Caucasian-vs-Asian |
8.175000E-01 |
| AfricanAmerican-vs-Asian |
3.417800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.663000E-01 |
| Normal-vs-Female |
2.024400E-01 |
| Male-vs-Female |
9.873800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.259400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.056400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.000400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.805590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.988400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.369500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.605000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.991200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.784400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.011400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.338400E-03 |
| Classical-VS-Follicular |
8.571200E-01 |
| Classical-VS-Other |
8.009800E-01 |
| Classical-VS-Normal |
5.204400E-01 |
| Tall-VS-Follicular |
2.281700E-02 |
| Tall-VS-Other |
7.394300E-02 |
| Tall-VS-Normal |
3.484600E-03 |
| Follicular-VS-Other |
7.899400E-01 |
| Follicular-VS-Normal |
5.320600E-01 |
| Other-VS-Normal |
9.706400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.915580E-01 |
| Normal-vs-N1 |
2.552400E-02 |
| N0-vs-N1 |
2.259600E-01 |
|
|
